Impact of resolvin mediators in the immunopathology of diabetes and wound healing. (3rd June 2021)
- Record Type:
- Journal Article
- Title:
- Impact of resolvin mediators in the immunopathology of diabetes and wound healing. (3rd June 2021)
- Main Title:
- Impact of resolvin mediators in the immunopathology of diabetes and wound healing
- Authors:
- Shofler, David
Rai, Vikrant
Mansager, Sarah
Cramer, Kira
Agrawal, Devendra K. - Abstract:
- ABSTRACT: Introduction : Wound healing in diabetes may be delayed by persistent wound infection due to deficient immune and cellular response to tissue injury. Hyperglycemia due to decreased insulin availability and increased insulin resistance affects the immune response of the body. Accumulation of inflammatory immune cells and pro-inflammatory cytokines results in chronic inflammation and an altered resolution and remodeling phase of wound healing. Areas covered : Pro-resolving mediators called 'resolvins' target the resolution phase of wound healing and are becoming an area of increased interest. Resolvins stimulate self-limited innate immune responses and enhance innate microbial killing and clearance. Resolvins resolve inflammation by decreasing neutrophil infiltration and transmigration, increasing the phagocytic activity of macrophages, decreasing adipose tissue macrophages, downregulating platelet activation, suppressing nuclear factor-kappa beta activation, promoting the apoptosis of polymorphonuclear leukocytes, and improving insulin sensitivity. This review discusses the role of resolvins in diabetic wound healing and potential therapeutic strategies. The review is based on a literature search of PubMed and the Web of Science restricted to publications between January 2001 and October 2020. Expert opinion : There is increasing support for the use of resolvins in clinical applications related to diabetes and wound healing. Further research will help clarify thisABSTRACT: Introduction : Wound healing in diabetes may be delayed by persistent wound infection due to deficient immune and cellular response to tissue injury. Hyperglycemia due to decreased insulin availability and increased insulin resistance affects the immune response of the body. Accumulation of inflammatory immune cells and pro-inflammatory cytokines results in chronic inflammation and an altered resolution and remodeling phase of wound healing. Areas covered : Pro-resolving mediators called 'resolvins' target the resolution phase of wound healing and are becoming an area of increased interest. Resolvins stimulate self-limited innate immune responses and enhance innate microbial killing and clearance. Resolvins resolve inflammation by decreasing neutrophil infiltration and transmigration, increasing the phagocytic activity of macrophages, decreasing adipose tissue macrophages, downregulating platelet activation, suppressing nuclear factor-kappa beta activation, promoting the apoptosis of polymorphonuclear leukocytes, and improving insulin sensitivity. This review discusses the role of resolvins in diabetic wound healing and potential therapeutic strategies. The review is based on a literature search of PubMed and the Web of Science restricted to publications between January 2001 and October 2020. Expert opinion : There is increasing support for the use of resolvins in clinical applications related to diabetes and wound healing. Further research will help clarify this potential. … (more)
- Is Part Of:
- Expert review of clinical immunology. Volume 17:Number 6(2021)
- Journal:
- Expert review of clinical immunology
- Issue:
- Volume 17:Number 6(2021)
- Issue Display:
- Volume 17, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 17
- Issue:
- 6
- Issue Sort Value:
- 2021-0017-0006-0000
- Page Start:
- 681
- Page End:
- 690
- Publication Date:
- 2021-06-03
- Subjects:
- Diabetic wound -- chronic inflammation -- delayed wound healing -- endogenous pro-resolving mediators -- e-resolvins -- d-resolvins
Clinical immunology -- Periodicals
616.079 - Journal URLs:
- http://www.tandfonline.com/toc/ierm20/current ↗
http://www.future-drugs.com/loi/eci ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/1744666X.2021.1912598 ↗
- Languages:
- English
- ISSNs:
- 1744-666X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002985
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 18819.xml